47.57
-0.83(-1.71%)
Currency In USD
| Previous Close | 48.4 |
| Open | 48.74 |
| Day High | 48.74 |
| Day Low | 46.45 |
| 52-Week High | 59.23 |
| 52-Week Low | 20.85 |
| Volume | 451,995 |
| Average Volume | 594,879 |
| Market Cap | 1.76B |
| PE | -164.03 |
| EPS | -0.29 |
| Moving Average 50 Days | 38.66 |
| Moving Average 200 Days | 31.75 |
| Change | -0.83 |
If you invested $1000 in Harrow Health, Inc. (HROW) 10 years ago, it would be worth $7,409.66 as of September 30, 2025 at a share price of $47.57. Whereas If you bought $1000 worth of Harrow Health, Inc. (HROW) shares 5 years ago, it would be worth $8,509.84 as of September 30, 2025 at a share price of $47.57.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Harrow to Acquire Melt Pharmaceuticals
GlobeNewswire Inc.
Sep 26, 2025 11:00 AM GMT
NASHVILLE, Tenn., Sept. 26, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that it has entered into an agreement to acquire Melt Pharmaceuticals, Inc.,
Harrow Launches Harrow Access for All (HAFA)
GlobeNewswire Inc.
Sep 25, 2025 8:05 PM GMT
HAFA to Expand Harrow’s Innovative Market Access Model Across Ophthalmic Portfolio Program will be available in late 2025 through the HarrowAccess.com Portal NASHVILLE, Tenn., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading prov
Harrow Announces Agenda and Speakers for Investor & Analyst Day
GlobeNewswire Inc.
Sep 15, 2025 11:00 AM GMT
NASHVILLE, Tenn., Sept. 15, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced the agenda for its upcoming Investor & Analyst Day on Friday, September 26,